News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cambridge Major Laboratories, Inc. Dedicates New Large-Scale Active Pharmaceutical Ingredient (API) Facility


7/22/2009 8:36:31 AM

GERMANTOWN, Wis.--(BUSINESS WIRE)--Cambridge Major Laboratories (CML) announces it will be dedicating its new large scale Active Pharmaceutical Ingredient (API) manufacturing facility in Germantown, WI, USA on July 30, 2009. The state-of-the-art facility provides a high quality, US-based API supply option for the pharmaceutical and biotechnology industries, and is in response to CML’s need for larger capacity fueled by its growing pipeline of developmental and commercial manufacturing projects.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES